Featuring 12 all-new chapters and fully aligned with the revised DSM-5-TR classification, this two-volume text offers an unrivaled, in-depth look at the rapidly evolving field of neuropsychopharmacology.

"Now in its sixth edition, The American Psychiatric Association Publishing Textbook of Psychopharmacology remains the field's most comprehensive guide to the theory and practice of psychopharmacology. This extensively updated new edition features the expertise of more than 160 contributors, including more than 75 new authors. Twelve new chapters have been added to cover important key areas in this rapidly evolving specialty, including personalized medicine in psychiatry; the role of artificial intelligence and machine learning in the field; new agents with novel mechanisms, such as the neurosteroid antidepressant brexanolone and the atypical antipsychotic pimavanserin; use of investigational agents, such as psychedelics, in psychiatric treatment; evidence-based treatment of PTSD, OCD, autism spectrum disorder, and alcohol use disorder; and much more. Unrivaled in its rigor and relevance, The American Psychiatric Association Publishing Textbook of Psychopharmacology is an indispensable resource for all clinicians who prescribe psychotropic medications"--